SGLT-i Use in Diabetic Foot Ulcer Disease

CompletedOBSERVATIONAL
Enrollment

21

Participants

Timeline

Start Date

December 5, 2023

Primary Completion Date

February 28, 2024

Study Completion Date

April 30, 2024

Conditions
Diabetic Foot Ulcer
Interventions
OTHER

eDelphi method

This is a Delphi technique-based study using a purposive sample of convenience. Consensus development methods will be used to generate clinical guidelines, endorsed by key clinical groups, on the use of SGLT2i's in patients with diabetic foot ulcer disease, including acknowledgement of specific scenarios or patient characteristics that may influence these guidelines.

Trial Locations (1)

Unknown

University of Leicester, Leicester

All Listed Sponsors
lead

University of Leicester

OTHER

NCT06000722 - SGLT-i Use in Diabetic Foot Ulcer Disease | Biotech Hunter | Biotech Hunter